Prothena Income Tax Expense vs Total Revenue Analysis

PRTA Stock

USD 20.81 0.60 2.97%

Prothena Plc financial indicator trend analysis is much more than just breaking down Prothena plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Prothena plc is a good investment. Please check the relationship between Prothena Plc Income Tax Expense and its Total Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

Income Tax Expense vs Total Revenue

Income Tax Expense vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Prothena plc Income Tax Expense account and Total Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Prothena Plc's Income Tax Expense and Total Revenue is -0.21. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Prothena plc, assuming nothing else is changed. The correlation between historical values of Prothena Plc's Income Tax Expense and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of Prothena plc are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Income Tax Expense i.e., Prothena Plc's Income Tax Expense and Total Revenue go up and down completely randomly.

Correlation Coefficient

-0.21

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Income Tax Expense

Total Revenue

Total revenue comprises all receipts Prothena plc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Prothena Plc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Prothena plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.As of June 2, 2024, Selling General Administrative is expected to decline to about 34.6 M. The current year's Tax Provision is expected to grow to about (12.8 M)

	2021	2022	2023	2024 (projected)
Total Operating Expenses	128.6M	185.5M	282.4M	296.5M
Cost Of Revenue	82.3M	6.7M	8.4M	8.0M

Total Operating Expenses Cost Of Revenue

Prothena Plc fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Other Assets	Total Liab	Property Plant Equipment	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Common Stock
Common Stock Shares Outstanding		0.94	-0.17	0.77	0.86	0.76	0.5	0.76	0.9	0.23	0.42	0.7	0.47	0.78	0.58	0.98	-0.14	0.93	-0.87	-0.9	0.93	0.93	0.28	1.0	-0.25	0.99
Total Assets	0.94		-0.13	0.79	0.98	0.6	0.53	0.68	0.78	0.31	0.41	0.69	0.47	0.63	0.62	0.95	0.04	1.0	-0.92	-0.79	0.98	0.98	0.26	0.95	-0.27	0.96
Other Current Liab	-0.17	-0.13		-0.05	-0.03	-0.47	-0.18	-0.27	-0.35	-0.26	-0.26	-0.31	-0.4	-0.44	-0.29	-0.19	-0.11	-0.11	0.15	0.31	-0.12	-0.12	-0.39	-0.2	0.4	-0.18
Total Current Liabilities	0.77	0.79	-0.05		0.79	0.49	0.88	0.85	0.57	0.28	0.35	0.62	0.79	0.39	0.87	0.79	-0.17	0.8	-0.87	-0.8	0.82	0.82	0.62	0.79	-0.58	0.83
Total Stockholder Equity	0.86	0.98	-0.03	0.79		0.45	0.57	0.6	0.62	0.27	0.31	0.59	0.48	0.45	0.66	0.87	0.1	0.98	-0.91	-0.68	0.96	0.96	0.3	0.87	-0.33	0.89
Other Liab	0.76	0.6	-0.47	0.49	0.45		0.28	0.74	0.87	-0.05	0.21	0.44	0.45	0.89	0.41	0.78	-0.36	0.61	-0.65	-0.9	0.62	0.62	0.3	0.76	-0.22	0.77
Accounts Payable	0.5	0.53	-0.18	0.88	0.57	0.28		0.74	0.28	0.28	0.29	0.51	0.92	0.13	0.94	0.53	-0.02	0.54	-0.65	-0.61	0.55	0.55	0.85	0.54	-0.83	0.57
Other Assets	0.76	0.68	-0.27	0.85	0.6	0.74	0.74		0.7	0.13	0.28	0.58	0.77	0.6	0.76	0.81	-0.3	0.68	-0.76	-0.92	0.7	0.7	0.59	0.78	-0.49	0.81
Total Liab	0.9	0.78	-0.35	0.57	0.62	0.87	0.28	0.7		0.34	0.57	0.76	0.3	0.97	0.33	0.88	-0.15	0.75	-0.67	-0.87	0.74	0.74	0.08	0.88	-0.02	0.87
Property Plant Equipment	0.23	0.31	-0.26	0.28	0.27	-0.05	0.28	0.13	0.34		0.93	0.81	0.06	0.3	0.13	0.19	0.48	0.24	-0.11	-0.12	0.21	0.21	-0.08	0.23	0.04	0.21
Property Plant And Equipment Net	0.42	0.41	-0.26	0.35	0.31	0.21	0.29	0.28	0.57	0.93		0.9	0.09	0.55	0.14	0.36	0.39	0.33	-0.19	-0.33	0.3	0.3	-0.07	0.41	0.07	0.38
Non Current Assets Total	0.7	0.69	-0.31	0.62	0.59	0.44	0.51	0.58	0.76	0.81	0.9		0.37	0.68	0.42	0.68	0.2	0.62	-0.51	-0.63	0.61	0.61	0.15	0.71	-0.15	0.69
Non Currrent Assets Other	0.47	0.47	-0.4	0.79	0.48	0.45	0.92	0.77	0.3	0.06	0.09	0.37		0.19	0.94	0.52	-0.19	0.48	-0.65	-0.66	0.52	0.52	0.94	0.52	-0.92	0.55
Non Current Liabilities Total	0.78	0.63	-0.44	0.39	0.45	0.89	0.13	0.6	0.97	0.3	0.55	0.68	0.19		0.19	0.76	-0.14	0.6	-0.53	-0.8	0.6	0.6	0.0	0.76	0.07	0.74
Other Current Assets	0.58	0.62	-0.29	0.87	0.66	0.41	0.94	0.76	0.33	0.13	0.14	0.42	0.94	0.19		0.61	-0.06	0.64	-0.77	-0.68	0.66	0.66	0.89	0.63	-0.87	0.66
Other Stockholder Equity	0.98	0.95	-0.19	0.79	0.87	0.78	0.53	0.81	0.88	0.19	0.36	0.68	0.52	0.76	0.61		-0.16	0.94	-0.89	-0.92	0.94	0.94	0.31	0.99	-0.27	0.99
Property Plant And Equipment Gross	-0.14	0.04	-0.11	-0.17	0.1	-0.36	-0.02	-0.3	-0.15	0.48	0.39	0.2	-0.19	-0.14	-0.06	-0.16		0.01	0.2	0.31	-0.14	-0.14	-0.11	-0.11	0.07	-0.16
Total Current Assets	0.93	1.0	-0.11	0.8	0.98	0.61	0.54	0.68	0.75	0.24	0.33	0.62	0.48	0.6	0.64	0.94	0.01		-0.94	-0.79	0.98	0.98	0.29	0.94	-0.3	0.95
Net Debt	-0.87	-0.92	0.15	-0.87	-0.91	-0.65	-0.65	-0.76	-0.67	-0.11	-0.19	-0.51	-0.65	-0.53	-0.77	-0.89	0.2	-0.94		0.84	-0.97	-0.97	-0.47	-0.88	0.47	-0.92
Retained Earnings	-0.9	-0.79	0.31	-0.8	-0.68	-0.9	-0.61	-0.92	-0.87	-0.12	-0.33	-0.63	-0.66	-0.8	-0.68	-0.92	0.31	-0.79	0.84		-0.81	-0.81	-0.46	-0.91	0.39	-0.92
Cash	0.93	0.98	-0.12	0.82	0.96	0.62	0.55	0.7	0.74	0.21	0.3	0.61	0.52	0.6	0.66	0.94	-0.14	0.98	-0.97	-0.81		1.0	0.32	0.93	-0.33	0.96
Cash And Short Term Investments	0.93	0.98	-0.12	0.82	0.96	0.62	0.55	0.7	0.74	0.21	0.3	0.61	0.52	0.6	0.66	0.94	-0.14	0.98	-0.97	-0.81	1.0		0.32	0.93	-0.33	0.96
Net Receivables	0.28	0.26	-0.39	0.62	0.3	0.3	0.85	0.59	0.08	-0.08	-0.07	0.15	0.94	0.0	0.89	0.31	-0.11	0.29	-0.47	-0.46	0.32	0.32		0.33	-0.98	0.35
Common Stock Total Equity	1.0	0.95	-0.2	0.79	0.87	0.76	0.54	0.78	0.88	0.23	0.41	0.71	0.52	0.76	0.63	0.99	-0.11	0.94	-0.88	-0.91	0.93	0.93	0.33		-0.3	0.99
Inventory	-0.25	-0.27	0.4	-0.58	-0.33	-0.22	-0.83	-0.49	-0.02	0.04	0.07	-0.15	-0.92	0.07	-0.87	-0.27	0.07	-0.3	0.47	0.39	-0.33	-0.33	-0.98	-0.3		-0.32
Common Stock	0.99	0.96	-0.18	0.83	0.89	0.77	0.57	0.81	0.87	0.21	0.38	0.69	0.55	0.74	0.66	0.99	-0.16	0.95	-0.92	-0.92	0.96	0.96	0.35	0.99	-0.32

Click cells to compare fundamentals

Prothena Plc Account Relationship Matchups

Prothena Plc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	39.9M	39.9M	48.5M	47.4M	53.2M	35.1M
Total Assets	419.3M	333.0M	609.4M	758.0M	696.4M	414.8M
Other Current Liab	6.8M	11.3M	16.2M	23.0M	(37.0M)	(35.2M)
Total Current Liabilities	17.7M	25.8M	33.5M	50.1M	56.9M	59.7M
Total Stockholder Equity	272.9M	184.0M	466.0M	622.0M	561.4M	325.8M
Accounts Payable	1.2M	4.1M	3.7M	9.3M	25.4M	26.7M
Other Assets	13.7M	31.1M	10.4M	30.9M	35.6M	37.3M
Total Liab	146.3M	149.0M	143.3M	136.0M	135.0M	89.0M
Property Plant Equipment	3.9M	2.6M	2.0M	8.0M	9.2M	16.9M
Property Plant And Equipment Net	27.1M	20.4M	14.1M	8.0M	16.0M	22.5M
Non Current Assets Total	40.9M	33.7M	24.6M	38.9M	57.1M	36.0M
Non Currrent Assets Other	3.8M	1.7M	3.4M	12.7M	40.2M	42.3M
Liabilities And Stockholders Equity	419.3M	333.0M	609.4M	758.0M	696.4M	446.4M
Non Current Liabilities Total	128.6M	123.1M	109.9M	85.8M	78.1M	67.8M
Other Current Assets	2.7M	2.5M	5.7M	8.7M	19.1M	20.1M
Other Stockholder Equity	944.4M	966.6M	1.2B	1.5B	1.5B	822.4M
Property Plant And Equipment Gross	27.1M	20.4M	14.1M	8.0M	23.4M	22.3M
Total Current Assets	378.4M	299.3M	584.8M	719.1M	639.3M	410.5M
Net Debt	(352.8M)	(277.5M)	(566.8M)	(703.9M)	(608.3M)	(577.9M)
Retained Earnings	(671.9M)	(783.0M)	(716.1M)	(833.0M)	(980.0M)	(931.0M)
Cash	375.7M	295.4M	579.1M	710.4M	620.2M	438.0M
Cash And Short Term Investments	375.7M	295.4M	579.1M	710.4M	620.2M	438.0M
Net Receivables	68K	15K	13K	62K	5.2M	5.4M
Net Tangible Assets	272.9M	184.0M	466.0M	622.0M	715.3M	381.1M
Retained Earnings Total Equity	(598.0M)	(671.9M)	(783.0M)	(716.1M)	(644.4M)	(676.7M)
Capital Surpluse	920.6M	944.4M	966.6M	1.2B	1.4B	801.6M
Deferred Long Term Liab	254K	110.4M	110.2M	102.9M	118.4M	124.3M
Short Term Debt	5.1M	5.5M	5.9M	6.5M	1.1M	1.1M
Non Current Liabilities Other	18.4M	12.9M	6.9M	553K	497.7K	472.8K
Short Long Term Debt Total	22.9M	17.8M	12.3M	6.5M	11.8M	22.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
BAC	Bank of America
GM	General Motors

When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:

How To Invest In Prothena

Details

Is Prothena Stock a good investment?

Details

What is Prothena Plc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Prothena Stock analysis

When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.

	Transaction History View history of all your transactions and understand their impact on performance
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Global Correlations Find global opportunities by holding instruments from different markets
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios

Is Prothena Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.21)

Revenue Per Share

1.668

Quarterly Revenue Growth

(0.98)

Return On Assets

(0.20)

Return On Equity

(0.31)

The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Prothena Income Tax Expense vs Total Revenue Analysis

Income Tax Expense vs Total Revenue

Income Tax Expense vs Total Revenue Correlation Analysis

Correlation Coefficient

Income Tax Expense

Total Revenue

Prothena Plc fundamental ratios Correlations

Prothena Plc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Prothena Plc fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Prothena Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock Shares Outstanding
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.99	Other Stockholder Equity
Common Stock	+ 0.99	Other Stockholder Equity

Inventory	- 0.98	Net Receivables
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.94	Total Current Assets
Common Stock	- 0.92	Retained Earnings
Common Stock	- 0.92	Net Debt